Biomind Labs
Company Information
Biomind Labs is a biotechnology company developing fast-acting and controlled-release pharmaceuticals for neurological and neuropsychiatric disorders. Its pipeline spans programs for treatment-resistant depression, Alzheimer's disease, Parkinson's disease, fibromyalgia, chronic pain, addiction, and obesity.
Industry Focus and Technologies
Neuropharmaceuticals, CNS drug development, controlled-release drug delivery, neurological disorders, neuropsychiatry, and clinical-stage therapeutics.
Location
Toronto, Ontario, Canada
Company Size and Stage
Products, Platforms or Focus Areas
Pipeline candidates including BMND01, BMND02, BMND03, BMND05, BMND06, BMND07, BMND08, and BMND09, supported by tailored drug delivery systems and patent-backed neurotherapeutic development.